Sharp-1 regulates TGF-β signaling and skeletal muscle regeneration

Journal of Cell Science

Volumn 127, Issue 3, 2014, Pages 599-608

  Acharjee, Sujata ^a   Chung, Teng Kai ^a,b   Gopinadhan, Suma ^b   Shankar, Shilpa Rani ^b   Wang, Yaju ^b   Li, Li ^a   Vercherat, Cecile ^a   Gulbagci, Neriman Tuba ^a   Rossner, Moritz ^c   Taneja, Reshma ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Department of Psychiatry Nussbaumstr ^*  (Germany)

Author keywords

Degeneration; Fibrosis; Myofibroblast; Regeneration; Skeletal muscle; TGF

Indexed keywords

DEGENERATION; FIBROSIS; MYOFIBROBLAST; REGENERATION; SKELETAL MUSCLE; TGF-Β;

ANIMALS; CELL DIFFERENTIATION; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MUSCLE, SKELETAL; MYOFIBROBLASTS; REGENERATION; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84894066029     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.136648     Document Type: Article

References (47)

1. Allen, R. E. and Boxhorn, L. K. (1987). Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J. Cell. Physiol. 133, 567-572.
2. Azmi, S., Sun, H., Ozog, A. and Taneja, R. (2003). mSharp-1/DEC2, a basic helix-loop-helix protein functions as a transcriptional repressor of E box activity and Stra13 expression. J. Biol. Chem. 278, 20098-20109.
3. Azmi, S., Ozog, A. and Taneja, R. (2004). Sharp-1/DEC2 inhibits skeletal muscle differentiation through repression of myogenic transcription factors. J. Biol. Chem. 279, 52643-52652.
4. Barnard, J. A., Lyons, R. M. and Moses, H. L. (1990). The cell biology of transforming growth factor beta. Biochim. Biophys. Acta 1032, 79-87.
5. Bernasconi, P., Torchiana, E., Confalonieri, P., Brugnoni, R., Barresi, R., Mora, M., Cornelio, F., Morandi, L. and Mantegazza, R. (1995). Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J. Clin. Invest. 96, 1137-1144.
6. Bernasconi, P., Di Blasi, C., Mora, M., Morandi, L., Galbiati, S., Confalonieri, P., Cornelio, F. and Mantegazza, R. (1999). Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies. Neuromuscul. Disord. 9, 28-33.
7. Border, W. A. and Noble, N. A. (1994). Transforming growth factor b in tissue fibrosis. N. Engl. J. Med. 331, 1286-1292.
8. Border, W. A. and Ruoslahti, E. (1992). Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90, 1-7.
9. Chargé , S. B. and Rudnicki, M. A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238.
10. Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., ap Rhys, C. M., Holm, T. M., Loeys, B. L. et al. (2007). Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13, 204-210.
11. Desmoulière, A., Geinoz, A., Gabbiani, F. and Gabbiani, G. (1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122, 103-111.
12. Elberg,G., Chen, L., Elberg, D., Chan,M. D., Logan, C. J. and Turman,M. A. (2008). MKL1 mediates TGF-beta1-induced alpha-smooth muscle actin expression in human renal epithelial cells. Am. J. Physiol. Renal Physiol. 294, F1116-F1128.
13. Flanders, K. C. (2004). Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 85, 47-64.
14. Fujimoto, K., Hamaguchi, H., Hashiba, T., Nakamura, T., Kawamoto, T., Sato, F., Noshiro, M., Bhawal, U. K., Suardita, K. and Kato, Y. (2007). Transcriptional repression by the basic helix-loop-helix protein Dec2: multiple mechanisms through E-box elements. Int. J. Mol. Med. 19, 925-932.
15. Garriga-Canut, M., Roopra, A. and Buckley, N. J. (2001). The basic helix-loophelix protein, sharp-1, represses transcription by a histone deacetylasedependent and histone deacetylase-independent mechanism. J. Biol. Chem. 276, 14821-14828.
16. Grinnell, F. (1994). Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 124, 401-404.
17. Gulbagci, N. T., Li, L., Ling, B., Gopinadhan, S., Walsh, M., Rossner, M., Nave, K. A. and Taneja, R. (2009). SHARP1/DEC2 inhibits adipogenic differentiation by regulating the activity of C/EBP. EMBO Rep. 10, 79-86.
18. Hawke, T. J. and Garry, D. J. (2001). Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534-551.
19. Heldin, C. H., Miyazono, K. and ten Dijke, P. (1997). TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
20. Huard, J., Li, Y. and Fu, F. H. (2002). Muscle injuries and repair: current trends in research. J. Bone Joint Surg. Am. 84-A, 822-832.
21. Husmann, I., Soulet, L., Gautron, J., Martelly, I. and Barritault, D. (1996). Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev. 7, 249-258.
22. Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A. and Border, W. A. (1996). Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat. Med. 2, 418-423.
23. Lefaucheur, J. P. and Sé bille, A. (1995). Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I. J. Neuroimmunol. 57, 85-91.
24. Li, Y., Foster, W., Deasy, B. M., Chan, Y., Prisk, V., Tang, Y., Cummins, J. and Huard, J. (2004). Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am. J. Pathol. 164, 1007-1019.
25. Li, Y., Li, J., Zhu, J., Sun, B., Branca, M., Tang, Y., Foster, W., Xiao, X. and Huard, J. (2007). Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol. Ther. 15, 1616-1622.
26. Ling, B. M., Gopinadhan, S., Kok, W. K., Shankar, S. R., Gopal, P., Bharathy, N., Wang, Y. and Taneja, R. (2012). G9a mediates Sharp-1-dependent inhibition of skeletal muscle differentiation. Mol. Biol. Cell 23, 4778-4785.
27. Liu, D., Black, B. L. and Derynck, R. (2001). TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15, 2950-2966.
28. Liu, J. J., Chung, T. K., Li, J. and Taneja, R. (2010). Sharp-1 modulates the cellular response to DNA damage. FEBS Lett. 584, 619-624.
29. Massagué , J., Cheifetz, S., Endo, T. and Nadal-Ginard, B. (1986). Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 83, 8206-8210.
30. Massaous, J. and Hata, A. (1997). TGF-β signalling through the Smad pathway. Trends Cell Biol. 7, 187-192.
31. Meng, X. M., Huang, X. R., Chung, A. C., Qin, W., Shao, X., Igarashi, P., Ju, W., Bottinger, E. P. and Lan, H. Y. (2010). Smad2 protects against TGF-beta/ Smad3-mediated renal fibrosis. J. Am. Soc. Nephrol. 21, 1477-1487.
32. Montagner, M., Enzo, E., Forcato, M., Zanconato, F., Parenti, A., Rampazzo, E., Basso, G., Leo, G., Rosato, A., Bicciato, S. et al. (2012). SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxiainducible factors. Nature 487, 380-384.
33. Morosetti, R., Mirabella, M., Gliubizzi, C., Broccolini, A., De Angelis, L., Tagliafico, E., Sampaolesi, M., Gidaro, T., Papacci, M., Roncaglia, E. et al. (2006). MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proc. Natl. Acad. Sci. USA 103, 16995-17000.
34. Moses, H. L., Yang, E. Y. and Pietenpol, J. A. (1990). TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63, 245-247. Murakami, N., McLennan, I. S., Nonaka, I., Koishi, K., Baker, C. and
35. Murakami, N., McLennan, I. S., Nonaka, I., Koishi, K., Baker, C. and Hammond-Tooke, G. (1999). Transforming growth factor-beta2 is elevated in skeletal muscle disorders. Muscle Nerve 22, 889-898.
36. Rossner, M. J., Oster, H., Wichert, S. P., Reinecke, L., Wehr, M. C., Reinecke, J., Eichele, G., Taneja, R. and Nave, K. A. (2008). Disturbed clockwork resetting in Sharp-1 and Sharp-2 single and double mutant mice. PLoS ONE 3, e2762.
37. Sato, F., Kawamura, H., Wu, Y., Sato, H., Jin, D., Bhawal, U. K., Kawamoto, T., Fujimoto, K., Noshiro, M., Seino, H. et al. (2012). The basic helix-loop-helix transcription factor DEC2 inhibits TGF-β-induced tumor progression in human pancreatic cancer BxPC-3 cells. Int. J. Mol. Med. 30, 495-501.
38. Serini, G. and Gabbiani, G. (1996). Modulation of a-smooth muscle actin expression in fibroblasts by transforming growth factor-β isoforms: an in vivo and in vitro study. Wound Repair Regen. 4, 278-287.
39. Serini, G., Bochaton-Piallat, M. L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L. and Gabbiani, G. (1998). The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J. Cell Biol. 142, 873-881.
40. Sun, H. and Taneja, R. (2000). Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC)-dependent and HDAC-independent mechanisms. Proc. Natl. Acad. Sci. USA 97, 4058-4063.
41. Sun, H., Ghaffari, S. and Taneja, R. (2007a). bHLH-Orange transcription factors in development and cancer. Translational Oncogenomics 2, 107-120.
42. Sun, H., Li, L., Vercherat, C., Gulbagci, N. T., Acharjee, S., Li, J., Chung, T. K., Thin, T. H. and Taneja, R. (2007b). Stra13 regulates satellite cell activation by antagonizing Notch signaling. J. Cell Biol. 177, 647-657.
43. Uezumi, A., Ito, T., Morikawa, D., Shimizu, N., Yoneda, T., Segawa, M., Yamaguchi, M., Ogawa, R., Matev, M. M., Miyagoe-Suzuki, Y. et al. (2011). Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J. Cell Sci. 124, 3654-3664.
44. Wang, Y., Shankar, S. R., Kher, D., Ling, B. M. and Taneja, R. (2013). Sumoylation of the basic helix-loop-helix transcription factor sharp-1 regulates recruitment of the histone methyltransferase G9a and function in myogenesis. J. Biol. Chem. 288, 17654-17662.
45. Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X. F. and Massagué , J. (1992). TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
46. Yamada K. and Miyamoto, K. (2005). Basic helix-loop-helix transcription factors, BHLHB2 and BHLHB3; their gene expressions are regulated by multiple extracellular stimuli. Front. Biosci. 10, 3151-3171.
47. Zhu, J., Li, Y., Shen, W., Qiao, C., Ambrosio, F., Lavasani, M., Nozaki, M., Branca, M. F. and Huard, J. (2007). Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. J. Biol. Chem. 282, 25852-25863.